• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄性大鼠的适口性、食物摄入量与行为饱腹感序列

Palatability, food intake and the behavioural satiety sequence in male rats.

作者信息

Ishii Y, Blundell J E, Halford J C G, Rodgers R J

机构信息

Behavioural Pharmacology Laboratory, School of Psychology, University of Leeds, LS2 9JT, Leeds, UK.

出版信息

Physiol Behav. 2003 Oct;80(1):37-47. doi: 10.1016/s0031-9384(03)00207-5.

DOI:10.1016/s0031-9384(03)00207-5
PMID:14568306
Abstract

Food intake is influenced not only by nutritional status but also by diverse environmental factors. Indeed, a unique quality of food reward is its strong modulation by palatability cues, such as taste, with animals generally preferring diets that are sweet and avoiding those that are either bitter or sour. As appetite suppressants (including those currently in development) could alter food intake by modifying taste sensitivity and/or palatability, the aim of the present study was to characterise the influence of taste adulteration on the normal structure of feeding behaviour, i.e., the behavioural satiety sequence (BSS). Adult male rats were initially habituated both to the basic test diet (mash) and the test arena. Following stabilisation of basal intake, a continuous monitoring technique was used to profile behaviour in weekly 1-h sessions during which the animals were presented, in counterbalanced order, with the basic diet (control) or one of four taste-adulterated variants (0.015% quinine, 0.04% quinine, 0.2% saccharin, 0.3% saccharin). Food intake was strongly suppressed by the higher quinine concentration but was not significantly altered by any of the other additives. Behavioural analysis revealed that this anorectic-like response to 0.04% quinine-adulterated food was associated with a significant reduction in the peak feeding response, highly atypical intermittent food sampling/digging and the virtual absence of resting behaviour. Importantly, this pattern of behavioural change is readily distinguishable from those seen in response to other manipulations that reduce intake, including selective anorectics, sedatives and psychostimulants. Despite the lack of significant effect on food intake or the duration of feeding behaviour, dietary adulteration with 0.015% quinine (and, to a lesser degree, 0.3% saccharin) produced some effects on behavioural structure/time course consistent with a mild aversive response, i.e., bouts of midsession food sampling and a delay in the transition from eating to resting. Data are discussed in relation to the specific behavioural signature to quinine-induced anorexia and its potential utility in identifying appetite suppressants that may modify intake via changes in taste sensitivity and/or palatability.

摘要

食物摄入量不仅受营养状况影响,还受多种环境因素影响。事实上,食物奖赏的一个独特特性是其受适口性线索(如味道)的强烈调节,动物通常更喜欢甜味食物,而避免苦味或酸味食物。由于食欲抑制剂(包括目前正在研发的那些)可能通过改变味觉敏感性和/或适口性来改变食物摄入量,本研究的目的是描述味觉掺假对正常进食行为结构(即行为饱腹感序列,BSS)的影响。成年雄性大鼠最初要适应基础测试饮食(糊状食物)和测试环境。在基础摄入量稳定后,采用连续监测技术,在每周1小时的时间段内记录行为,在此期间,给动物按平衡顺序喂食基础饮食(对照)或四种味觉掺假变体之一(0.015%奎宁、0.04%奎宁、0.2%糖精、0.3%糖精)。较高浓度的奎宁强烈抑制食物摄入,但其他添加剂均未显著改变食物摄入量。行为分析表明,对0.04%奎宁掺假食物的这种厌食样反应与峰值进食反应显著降低、高度非典型的间歇性食物采样/挖掘以及几乎没有休息行为有关。重要的是,这种行为变化模式很容易与因其他减少摄入量的操作(包括选择性厌食剂、镇静剂和精神兴奋剂)而出现的模式区分开来。尽管对食物摄入量或进食行为持续时间没有显著影响,但用0.015%奎宁(以及在较小程度上用0.3%糖精)进行饮食掺假对行为结构/时间进程产生了一些与轻度厌恶反应一致的影响,即中期食物采样发作以及从进食到休息的转变延迟。将结合奎宁诱导厌食的特定行为特征及其在识别可能通过改变味觉敏感性和/或适口性来改变摄入量的食欲抑制剂方面的潜在效用对数据进行讨论。

相似文献

1
Palatability, food intake and the behavioural satiety sequence in male rats.雄性大鼠的适口性、食物摄入量与行为饱腹感序列
Physiol Behav. 2003 Oct;80(1):37-47. doi: 10.1016/s0031-9384(03)00207-5.
2
Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite.行为饱足序列(BSS):在食欲的行为药理学中区分小麦和糠秕。
Pharmacol Biochem Behav. 2010 Nov;97(1):3-14. doi: 10.1016/j.pbb.2010.03.001. Epub 2010 Mar 7.
3
Effects of systematic variation in presatiation and fasting on the behavioural satiety sequence in male rats.预饱足和禁食的系统性变化对雄性大鼠行为饱足序列的影响。
Physiol Behav. 2003 Jul;79(2):227-38. doi: 10.1016/s0031-9384(03)00066-0.
4
Dietary quinine reduces body weight and food intake independent of aversive taste.饮食中的奎宁可减轻体重并减少食物摄入量,与厌恶味觉无关。
Physiol Behav. 1982 Dec;29(6):1171-3. doi: 10.1016/0031-9384(82)90315-8.
5
Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food.纳洛酮对给予美味食物的非饥饿雄性大鼠的行为选择性食欲减退作用。
Behav Brain Res. 2008 Mar 5;187(2):417-27. doi: 10.1016/j.bbr.2007.10.005. Epub 2007 Oct 13.
6
Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats.选择性食欲素-1受体拮抗剂SB-334867和氯化锂对大鼠行为饱腹感序列的不同影响。
Physiol Behav. 2004 Mar;81(1):129-40. doi: 10.1016/j.physbeh.2004.01.009.
7
Behavioural structure and mechanisms of anorexia: calibration of natural and abnormal inhibition of eating.厌食症的行为结构与机制:进食自然抑制与异常抑制的校准
Brain Res Bull. 1985 Oct;15(4):371-6. doi: 10.1016/0361-9230(85)90004-8.
8
The role of taste preference in the eating behavior of the albino rat.味觉偏好对白化大鼠进食行为的作用。
Physiol Behav. 1970 Mar;5(3):311-6. doi: 10.1016/0031-9384(70)90103-4.
9
Independent effects of diet palatability and fat content on bout size and daily intake in rats.饮食适口性和脂肪含量对大鼠进食量及每日摄入量的独立影响。
Physiol Behav. 2003 Nov;80(2-3):253-8. doi: 10.1016/j.physbeh.2003.07.007.
10
Ethanol, saccharin, and quinine: early ontogeny of taste responsiveness and intake.乙醇、糖精和奎宁:味觉反应性和摄入量的早期个体发生
Alcohol Clin Exp Res. 2008 Feb;32(2):294-305. doi: 10.1111/j.1530-0277.2007.00581.x. Epub 2007 Dec 21.

引用本文的文献

1
Re-evaluation of saccharin and its sodium, potassium and calcium salts (E 954) as food additives.重新评估糖精及其钠盐、钾盐和钙盐(E 954)作为食品添加剂的安全性。
EFSA J. 2024 Nov 15;22(11):e9044. doi: 10.2903/j.efsa.2024.9044. eCollection 2024 Nov.
2
The Metabolic Syndrome, a Human Disease.代谢综合征,一种人类疾病。
Int J Mol Sci. 2024 Feb 13;25(4):2251. doi: 10.3390/ijms25042251.
3
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.
国际基础和临床药理学联合会。CX. 5-羟色胺受体分类:药理学与功能。
Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552.
4
Trypsin inhibitors: promising candidate satietogenic proteins as complementary treatment for obesity and metabolic disorders?胰蛋白酶抑制剂:作为肥胖和代谢紊乱的辅助治疗有前途的饱腹感蛋白候选物?
J Enzyme Inhib Med Chem. 2019 Dec;34(1):405-419. doi: 10.1080/14756366.2018.1542387.
5
Challenges in quantifying food intake in rodents.啮齿动物食物摄入量量化中的挑战。
Brain Res. 2018 Aug 15;1693(Pt B):188-191. doi: 10.1016/j.brainres.2018.02.040.
6
Dietary challenges differentially affect activity and sleep/wake behavior in mus musculus: Isolating independent associations with diet/energy balance and body weight.饮食挑战对 Mus musculus 的活动和睡眠/觉醒行为有不同的影响:与饮食/能量平衡和体重有独立关联。
PLoS One. 2018 May 10;13(5):e0196743. doi: 10.1371/journal.pone.0196743. eCollection 2018.
7
A short history of the 5-HT receptor: from the choroid plexus to depression, obesity and addiction treatment.5-羟色胺受体简史:从脉络丛到抑郁症、肥胖症及成瘾治疗
Psychopharmacology (Berl). 2017 May;234(9-10):1395-1418. doi: 10.1007/s00213-017-4545-5. Epub 2017 Mar 7.
8
CB1 antagonism produces behaviors more consistent with satiety than reduced reward value in food-maintained responding in rats.在以食物维持反应的大鼠中,CB1拮抗剂产生的行为与饱腹感更为一致,而非奖励价值降低。
J Psychopharmacol. 2016 May;30(5):482-91. doi: 10.1177/0269881116639287. Epub 2016 Mar 22.
9
The Bitter Taste Receptor Agonist Quinine Reduces Calorie Intake and Increases the Postprandial Release of Cholecystokinin in Healthy Subjects.苦味受体激动剂奎宁可减少健康受试者的热量摄入并增加餐后胆囊收缩素的释放。
J Neurogastroenterol Motil. 2015 Oct 1;21(4):511-9. doi: 10.5056/jnm15028.
10
Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.奥氮平的长期治疗通过改变能量底物增加肥胖,并导致急性代谢副作用的脱敏。
Naunyn Schmiedebergs Arch Pharmacol. 2014 Feb;387(2):185-95. doi: 10.1007/s00210-013-0933-5. Epub 2013 Nov 5.